Comparison between Lamosaic India IPO and Onyx Biotec IPO.
IPO Details
Lamosaic India IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Onyx Biotec IPO is a SME Bookbuilding proposed to list at NSE SME.
Issue Size and Price
The total issue size of Lamosaic India IPO is up to ₹58.14 Cr whereas the issue size of the Onyx Biotec IPO is up to ₹27.85 Cr. The final issue price of Lamosaic India IPO is ₹200.00 per share and of Onyx Biotec IPO is ₹61.00 per share.
IPO Timetable
Lamosaic India IPO opens on Nov 21, 2024, while Onyx Biotec IPO opens on Nov 13, 2024. The closing date of Lamosaic India IPO and Onyx Biotec IPO is Nov 26, 2024, and Nov 18, 2024, respectively.
| | Lamosaic India IPO | Onyx Biotec IPO |
|---|
| Anchor Bid Date | | Nov 12, 2024 |
| Issue Open | Nov 21, 2024 | Nov 13, 2024 |
| Issue Close | Nov 26, 2024 | Nov 18, 2024 |
| Basis Of Allotment (Tentative) | Nov 27, 2024 | Nov 19, 2024 |
| Initiation of Refunds (Tentative) | Nov 28, 2024 | Nov 20, 2024 |
| Credit of Share (Tentative) | Nov 28, 2024 | Nov 20, 2024 |
| Listing date (Tentative) | Nov 29, 2024 | Nov 22, 2024 |
| Anchor Lockin End date 1 | | Dec 19, 2024 |
| Anchor Lockin End date 2 | | Feb 17, 2025 |
Financials & KPIs
Lamosaic India IPO P/E ratio is 17.69, as compared to Onyx Biotec IPO P/E ratio of 26.81.
Shares Offered
In the Lamosaic India IPO Retail Individual Investors (RII) are offered 14,53,500 shares while in Onyx Biotec IPO retail investors are offered 14,53,500 shares. Qualified Institutional Buyers (QIB) are offered in Lamosaic India IPO and 9,12,000 shares in Onyx Biotec IPO.
| | Lamosaic India IPO | Onyx Biotec IPO |
|---|
| Anchor Investor Reservation | | 13,66,000 shares |
| Market Maker Reservation | 1,53,000 shares | 2,44,000 shares |
| QIB | | 9,12,000 shares |
| NII | 14,53,500 shares | 6,88,000 shares |
| RII | 14,53,500 shares | 16,00,000 shares |
| Employee | | |
| Others | | |
| Total | 29,07,000 shares | 45,66,000 shares |
Bids Received (Subscription)
Lamosaic India IPO subscribed 1.77x in total, whereas Onyx Biotec IPO subscribed 138.77x.
